Aleks Radovic-Moreno, PhD

Dr. Radovic-Moreno is a Co-Founder of CommenSe and a Senior Associate at PureTech. He was previously a Research Scientist at the biotech startup AuraSense Therapeutics, where he was a lead inventor of the company's core immunotherapy platform, taking an idea from concept on paper to preclinical evidence of applicability in cancer, infectious disease, and auto-immune disease.

Dr. Radovic-Moreno completed his graduate work as an NSF Fellow in Robert Langer's lab at MIT, where he developed novel strategies for managing bacterial infections, including a novel vaccine candidate for chlamydia, a disease for which no vaccine currently exists, and an antibiotic-to-infection targeting strategy with the potential to maximize treatment efficacy while minimizing side effects and impact on commensal flora.

Dr. Radovic-Moreno received his B.S. in Chemical Engineering from the Pennsylvania State University and Ph. D. in Chemical and Biomedical Engineering from MIT and the Harvard-MIT Division of Health Sciences & Technology.